Abstract

A bidirectional crosstalk between peripheral players of immunity and the central nervous system (CNS) exists. Hence, blood–brain barrier (BBB) breakdown is emerging as a participant mechanism of dysregulated peripheral–CNS interplay, promoting diseases. Here, we examine the implication of BBB damage in neurodegeneration, linking it to peripheral brain-directed autoantibodies and gut–brain axis mechanisms. As BBB breakdown is a factor contributing to, or even anticipating, neuronal dysfunction(s), we here identify contemporary pharmacological strategies that could be exploited to repair the BBB in disease conditions. Developing neurovascular, add on, therapeutic strategies may lead to a more efficacious pre-clinical to clinical transition with the goal of curbing the progression of neurodegeneration.

Highlights

  • Inhibition of PDGFR signalingVascular endothelial growth factor Cardiovascular Nitric oxide donor Analgesic, anti-inflammatory, antineoplastic

  • HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not

  • Blood–brain barrier (BBB) breakdown is emerging as a participant mechanism of dysregulated peripheral–central nervous system (CNS) interplay, promoting diseases

Read more

Summary

Inhibition of PDGFR signaling

Vascular endothelial growth factor Cardiovascular Nitric oxide donor Analgesic, anti-inflammatory, antineoplastic. Decreased JMJD3 gene expression, suppression of MMP-2, MMP-3, and MMP-9 gene activation Binding to FRP2 receptor, inhibition of phospholipase-2

Prevention of transplant rejection
Inflammatory conditions
PERSPECTIVES AND CHALLENGES
AUTHOR CONTRIBUTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.